Baudax Bio, Inc. Annual Operating Income (Loss) in USD from 2018 to 2022

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Baudax Bio, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2018 to 2022.
  • Baudax Bio, Inc. Operating Income (Loss) for the quarter ending September 30, 2023 was -$1.78M, a 50.3% increase year-over-year.
  • Baudax Bio, Inc. Operating Income (Loss) for the twelve months ending September 30, 2023 was -$16.4M, a 293% decline year-over-year.
  • Baudax Bio, Inc. annual Operating Income (Loss) for 2022 was -$17.9M, a 29.8% increase from 2021.
  • Baudax Bio, Inc. annual Operating Income (Loss) for 2021 was -$25.5M, a 65.9% increase from 2020.
  • Baudax Bio, Inc. annual Operating Income (Loss) for 2020 was -$74.8M, a 130% decline from 2019.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 -$17.9M +$7.61M +29.8% Jan 1, 2022 Dec 31, 2022 8-K 2023-06-28
2021 -$25.5M +$49.3M +65.9% Jan 1, 2021 Dec 31, 2021 8-K 2023-06-28
2020 -$74.8M -$42.3M -130% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-16
2019 -$32.5M +$41M +55.8% Jan 1, 2019 Dec 31, 2019 10-K 2021-02-16
2018 -$73.5M Jan 1, 2018 Dec 31, 2018 10-K 2020-02-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.